University of Chicago’s Pyxis Oncology PYXS Stock Holding History

University of Chicago’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$147K	Hold	48,731	–	–	0.03%	14
2026 Q1	$71.1K	Hold	48,731	–	–	0.02%	13
2025 Q4	$56K	Hold	48,731	–	–	0.03%	12
2025 Q3	$108K	Hold	48,731	–	–	0.05%	11
2025 Q2	$53.6K	Hold	48,731	–	–	0.05%	11
2025 Q1	$47.8K	Hold	48,731	–	–	0.07%	12
2024 Q4	$76K	Hold	48,731	–	–	0.07%	5
2024 Q3	$179K	Hold	48,731	–	–	0.15%	5
2024 Q2	$161K	Hold	48,731	–	–	0.12%	7
2024 Q1	$208K	Hold	48,731	–	–	0.3%	6
2023 Q4	$87.7K	Hold	48,731	–	–	0.12%	8
2023 Q3	$97K	Hold	48,731	–	–	0.06%	6
2023 Q2	$125K	Hold	48,731	–	–	0.06%	6
2023 Q1	$195K	Hold	48,731	–	–	0.09%	5
2022 Q4	$65.3K	Buy	+48,731	New	+$73.1K	0.05%	5

Other funds holding PYXS

GGI

GordonMD Global Investments Beverely Hills, California $207M AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

University of Chicago's PYXS Position: Q2 2026 in Review

University of Chicago held its Pyxis Oncology (PYXS) position steady in Q2 2026 at 48,731 shares worth $147K. The position accounts for 0.03% of the portfolio, ranked #14.

University of Chicago first reported a position in PYXS in Q4 2022 and has held it in 15 quarters since. The position peaked at $208K in Q1 2024. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

University of Chicago held 48,731 shares of Pyxis Oncology worth $147K as of Q2 2026.
University of Chicago left its Pyxis Oncology share count unchanged in Q2 2026.
Pyxis Oncology made up 0.03% of University of Chicago's portfolio in Q2 2026, its #14 holding.
University of Chicago first reported a position in Pyxis Oncology in Q4 2022 and has held it in 15 quarters since.
University of Chicago's Pyxis Oncology position peaked at $208K in Q1 2024.
76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on University of Chicago's 13F filing for Q2 2026, filed 14 Aug 2026.